This is a good find Vulcarum. The fact that Teva is launching it's smart inhaler now to the UK general market even without reimbursements like the US is offering is a very positive sign for Adherium's UK operation. Teva would have done it's home work first before making this decision. I don't see any mention of how they plan to integrate their product. Maybe keeping that info close to their chest.
ADR Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
